Global Pharmaceuticals & Biotech Most Popular Stocks

Celltrion

Market Cap: ₩33.9t

Develops and produces drugs based on proteins for the treatment of oncology in South Korea.

BioNTech

Market Cap: US$23.7b

A biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany.

Bayer

Market Cap: €20.7b

Operates as a life science company worldwide.

Galderma Group

Market Cap: CHF 18.6b

Operates as a dermatology company worldwide.

Mettler-Toledo International

Market Cap: US$20.9b

Manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally.

Sartorius Stedim Biotech

Market Cap: €18.2b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

WuXi AppTec

Market Cap: CN¥151.1b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People’s Republic of China, the United States, Europe, and internationally.

Natera

Market Cap: US$20.0b

A diagnostics company, provides molecular testing services worldwide.

Waters

Market Cap: US$19.1b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Royalty Pharma

Market Cap: US$18.8b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Summit Therapeutics

Market Cap: US$18.2b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the United States, and the United Kingdom.

Divi's Laboratories

Market Cap: ₹1.5t

Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Biogen

Market Cap: US$17.4b

Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe, Germany, Asia, and internationally.

Sandoz Group

Market Cap: CHF 14.0b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥125.1b

Engages in the manufacture and sale of Chinese medicines under the Pien Tze Huang brand in China and internationally.

Astellas Pharma

Market Cap: JP¥2.4t

Manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally.

Hansoh Pharmaceutical Group

Market Cap: HK$131.1b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Teva Pharmaceutical Industries

Market Cap: US$15.6b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

ALTEOGEN

Market Cap: ₩20.9t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

West Pharmaceutical Services

Market Cap: US$14.6b

Designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

Shionogi

Market Cap: JP¥2.0t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

Cipla

Market Cap: ₹1.2t

Engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally.

Sichuan Biokin PharmaceuticalLtd

Market Cap: CN¥103.9b

Engages in the research and development, production, and marketing of small molecule chemical, macromolecular biological, and antibody-drug conjugate drugs in China and internationally.

Yunnan Baiyao GroupLtd

Market Cap: CN¥102.5b

Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.

Insmed

Market Cap: US$13.1b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Torrent Pharmaceuticals

Market Cap: ₹1.1t

Engages in the research, development, manufacturing, and marketing of generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.

United Therapeutics

Market Cap: US$12.8b

A biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.

Genmab

Market Cap: DKK 81.9b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Mankind Pharma

Market Cap: ₹1.1t

Develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally.

Beijing Wantai Biological Pharmacy Enterprise

Market Cap: CN¥85.2b

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.0b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Dr. Reddy's Laboratories

Market Cap: ₹969.5b

Operates as an integrated pharmaceutical company worldwide.

BioMarin Pharmaceutical

Market Cap: US$11.3b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Illumina

Market Cap: US$11.3b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Incyte

Market Cap: US$11.3b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

ICON

Market Cap: US$11.3b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.